Presurgical evaluation of drug-resistant paediatric focal epilepsy with PISCOM compared to SISCOM and FDG-PET

Epilepsy is a chronic neurological disease with a significant impact on the quality of life of patients [1]. Approximately 40% of patients with focal epilepsy are drug-resistant [2]. Surgical treatment should be considered in these cases. Seizure freedom or a marked (>90%) reduction in seizures in approximately two-thirds of cases can be achieved with epilepsy surgery in children [3,4]. Furthermore, in younger patients, early seizure control can avoid developmental delays [5].

0